retatrutide phase 2 nejm weight loss 48 weeks VisualAbstract: reduces body by 17.5% in patients with obesity Phase 2 Trial of Retatrutide

D.DruckerD

Mechanism of Action Semaglutide : A GLP-1 receptor agonist that works by mimicking the hormone GLP-1 to control hunger and blood sugar

References: Matheson EM, et al

Understanding your unique predispositions can help you and your provider choose a formulation, dose, and escalation schedule with better tolerability odds

GLP-1 Weight Loss Drugs: Coverage Under Medicaid and Other Health Plans Last Updated: March 2025 Over the past six months, states have been proactive in their consideration or reconsideration of next steps pertaining to coverage of Glucagon-like Peptide (GLP)-1s

Saxagliptin therapy was associated with a significantly increased rate of hospitalization due to heart failure in comparison to standard therapy (3.5% vs